| 注册
首页|期刊导航|临床肝胆病杂志|代谢相关脂肪性肝病多器官损伤的病理机制

代谢相关脂肪性肝病多器官损伤的病理机制

蒋丽娜 赵景民

临床肝胆病杂志2025,Vol.41Issue(9):1729-1736,8.
临床肝胆病杂志2025,Vol.41Issue(9):1729-1736,8.DOI:10.12449/JCH250903

代谢相关脂肪性肝病多器官损伤的病理机制

Pathological mechanism of multi-organ injuries in metabolic dysfunction-associated fatty liver disease

蒋丽娜 1赵景民1

作者信息

  • 1. 中国人民解放军总医院第五医学中心,北京 100039
  • 折叠

摘要

Abstract

Metabolic dysfunction-associated fatty liver disease(MAFLD)and its progressive form,metabolic dysfunction-associated steatohepatitis(MASH),have emerged as significant types of chronic liver disease worldwide and are closely associated with metabolic syndrome.The liver-extrahepatic organ/tissue axis and the"spill-over effect"of intrahepatic inflammation play pivotal roles in the pathogenesis and progression of MAFLD/MASH,significantly impacting multi-organ metabolic homeostasis and leading to various extrahepatic injuries.These include cardiovascular diseases,sarcopenia,chronic kidney disease,non-alcoholic fatty pancreas disease,polycystic ovary syndrome,hepatocellular carcinoma,and various related solid tumors.There is a notable epidemiological link between MAFLD and the development of both liver cancer and extrahepatic malignancies.The risk of associated tumorigenesis is related to multiple factors,including persistent metabolic disorders,chronic low-grade inflammation,and gut microbiota dysbiosis.Recent research perspectives have shifted from focusing solely on hepatic pathology to recognizing systemic metabolic dysregulation,emphasizing the central role of liver-extrahepatic organ interactions in disease progression.This article aims to explore the pathogenesis of MAFLD/MASH and to review the mechanisms underlying related multi-organ extrahepatic injuries.

关键词

代谢相关脂肪性肝病/多器官损伤/病理学

Key words

Metabolic Dysfunction-associated Fatty Liver Disease/Multi-organ Injuries/Pathology

引用本文复制引用

蒋丽娜,赵景民..代谢相关脂肪性肝病多器官损伤的病理机制[J].临床肝胆病杂志,2025,41(9):1729-1736,8.

基金项目

国家重点研发计划(2023YFC2308104,2023YFC2308100) (2023YFC2308104,2023YFC2308100)

北京市医院管理中心临床医学发展专项经费(ZLRK202301) (ZLRK202301)

国家自然科学基金(92159305) National Key R&D Program of China(2023YFC2308104,2023YFC2308100) (92159305)

Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support(ZLRK202301) (ZLRK202301)

National Natural Science Foundation of China(92159305) (92159305)

临床肝胆病杂志

OA北大核心

1001-5256

访问量0
|
下载量0
段落导航相关论文